ArticleCell reports. Medicine2025

A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy.

Masatoshi Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.